Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-25 @ 2:40 AM
NCT ID:
NCT05265234
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years of age
* Atopic dermatitis (AD) affecting ≥10% body surface area (BSA) at baseline
* IGA score ≥3, on the IGA scale of 0-4 at baseline
* Eczema Area and Severity Index (EASI) score of ≥16 at baseline
Exclusion Criteria:
* Prior treatment with Dupilumab (REGN668/SAR231893)
* Treatment with TCS or topical calcineurin inhibitors (TCI) within 2 weeks before the baseline visit
* Bodyweight \<30 kg (65lb) at Baseline
* Known or suspected immunodeficiency including human immunodeficiency virus (HIV) infection
* Pregnancy, breastfeeding or planning to become pregnant or breastfeed during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05265234
Study Brief:
Protocol Section:
NCT05265234